AVNS News & Events

Sees 2026 revenue $700M-$720M vs. $701.2M in 2025.

Reports Q4 revenue $180.9M vs. last year. "I'm very pleased with our Q4 and full-year results, which demonstrate meaningful progress on our strategic priorities," said CEO David Pacitti. "Our organic growth remains healthy and positions us well for 2026. Our tariff mitigation efforts are on track, and we're beginning to see the impact of our cost management initiatives. I'm proud of our team's focus and commitment."

Avanos Medical (AVNS) and Siemens (SIEGY) Healthineers announced a strategic co-marketing agreement to advance outpatient and interventional pain care through an integrated ecosystem of imaging and radiofrequency ablation, or RFA, technologies. Avanos and Siemens Healthineers will equip ambulatory surgery centers, hospitals, and interventional pain practices with complementary technologies that aim to enhance accuracy, efficiency, and consistency in patient care. Siemens Healthineers mobile C-arm systems, including the Cios Select and Cios Flow, deliver advanced imaging, maneuverability, and reliability. Paired with Avanos' technologies, they aim to create a seamless workflow that supports smoother operations and better patient outcomes. The co-marketing agreement will initially focus on the U.S. market, with both companies collaborating on education, sales training, and joint marketing of the combined solution.